NYSE:RCUS Arcus Biosciences (RCUS) News Today $21.64 +1.06 (+5.15%) (As of 06/8/2023 ET) Add Compare Share Share Today's Range$19.74▼$21.7450-Day Range$16.97▼$22.0352-Week Range$15.70▼$36.13Volume1.00 million shsAverage Volume1.05 million shsMarket Capitalization$1.58 billionP/E RatioN/ADividend YieldN/APrice Target$41.44 HeadlinesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Get Arcus Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RCUS and its competitors with MarketBeat's FREE daily newsletter. Email Address RCUS Media Mentions By Week RCUS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RCUS News Sentiment▼0.300.51▲Average Medical News Sentiment RCUS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RCUS Articles This Week▼83▲RCUS Articles Average Week All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineArcus Biosciences, Inc. (NYSE:RCUS) Receives Average Rating of "Moderate Buy" from Analystsamericanbankingnews.com - June 6 at 5:16 AMGilead (GILD), Arcus Announce Results From Mid-Stage NSCLC Studyfinance.yahoo.com - June 5 at 6:21 PMBank of America Securities Sticks to Its Hold Rating for Arcus Biosciences (RCUS)markets.businessinsider.com - June 5 at 8:24 AMGSA Capital Partners LLP Buys Shares of 30,108 Arcus Biosciences, Inc. (NYSE:RCUS)marketbeat.com - June 5 at 8:05 AMEnvestnet Asset Management Inc. Purchases New Shares in Arcus Biosciences, Inc. (NYSE:RCUS)marketbeat.com - June 4 at 4:01 AMGilead and Arcus Announce Anti-TIGIT Domvanalimab Continues to Demonstrate Consistent Improvement in Progression-Free Survival in Non-Small Cell Lung Cancer Studyfinance.yahoo.com - June 3 at 1:48 PMHC Wainwright & Co. Reiterates Precision Biosciences (DTIL) Buy Recommendationmsn.com - June 2 at 7:37 AMVictory Capital Management Inc. Buys 44,983 Shares of Arcus Biosciences, Inc. (NYSE:RCUS)marketbeat.com - June 2 at 5:24 AMArcus Biosciences (RCUS) Receives a Hold from Bank of America Securitiesmarkets.businessinsider.com - June 1 at 9:58 AMArcus Biosciences, Inc. (NYSE:RCUS) Receives Consensus Rating of "Moderate Buy" from Analystsmarketbeat.com - June 1 at 2:28 AMArcus Biosciences to Participate in the Goldman Sachs 44th Annual Global Healthcare Conferencefinance.yahoo.com - May 30 at 8:04 PMPrincipal Financial Group Inc. Cuts Position in Arcus Biosciences, Inc. (NYSE:RCUS)marketbeat.com - May 30 at 4:57 AMArcus Biosciences (NYSE:RCUS) Shares Gap Up on Analyst Upgradeamericanbankingnews.com - May 28 at 1:28 AMCitigroup Maintains Arcus Biosciences (RCUS) Buy Recommendationmsn.com - May 27 at 8:23 AMUnusual Call Option Trade in Arcus Biosciences (RCUS) Worth $164.80Kmsn.com - May 27 at 3:23 AMBooz Allen Hamilton, Workday, Marvell Technology And Other Big Stocks Moving Higher On Fridaymsn.com - May 26 at 4:16 PMCitigroup Maintains Buy Rating for Arcus Biosciences: Here's What You Need To Knowmarkets.businessinsider.com - May 26 at 4:16 PMArcus, Iteos Soar On Roche's 'Meaningful' Results In A New Cancer Drug Classfinance.yahoo.com - May 26 at 4:16 PMArcus Biosciences Soars On Roche's 'Meaningful' Results In A New Cancer Drug Classfinance.yahoo.com - May 26 at 11:16 AM11,490 Shares in Arcus Biosciences, Inc. (NYSE:RCUS) Purchased by AXQ Capital LPmarketbeat.com - May 26 at 8:57 AMArcus Biosciences (NYSE:RCUS) Price Target Raised to $41.00 at Citigroupamericanbankingnews.com - May 26 at 7:51 AMMizuho Securities Reaffirms Their Buy Rating on Arcus Biosciences (RCUS)markets.businessinsider.com - May 26 at 1:29 AMPrecision BioSciences to Participate in Upcoming Stifel Genetic Medicines Dayfinance.yahoo.com - May 24 at 8:29 AMQ2 2023 Earnings Estimate for Arcus Biosciences, Inc. Issued By Wedbush (NYSE:RCUS)americanbankingnews.com - May 20 at 1:56 AMPresentations at the 2023 ASCO Annual Meeting Highlight Arcus Biosciences’ Expanding Portfolio of Investigational Medicines and Late-Stage Studies Across Multiple Types of Cancerfinance.yahoo.com - May 17 at 9:37 AMArcus Biosciences (NYSE:RCUS) Trading 6.5% Higher americanbankingnews.com - May 17 at 9:00 AMEquities Analysts Set Expectations for Arcus Biosciences, Inc.'s FY2023 Earnings (NYSE:RCUS)americanbankingnews.com - May 17 at 3:56 AMThe past three years for Arcus Biosciences (NYSE:RCUS) investors has not been profitablefinance.yahoo.com - May 16 at 3:22 PMGilead Sciences and Arcus Biosciences Expand Partnership to Include Research Programs in Inflammationfinance.yahoo.com - May 15 at 9:19 AMFY2023 EPS Estimates for Arcus Biosciences, Inc. (NYSE:RCUS) Lifted by Analystmarketbeat.com - May 15 at 3:27 AMArcus Biosciences, Inc. Expected to Earn Q2 2023 Earnings of ($1.23) Per Share (NYSE:RCUS)americanbankingnews.com - May 14 at 1:40 AMWedbush Reiterates Arcus Biosciences (RCUS) Outperform Recommendationmsn.com - May 12 at 7:58 AMWedbush Analysts Cut Earnings Estimates for Arcus Biosciences, Inc. (NYSE:RCUS)marketbeat.com - May 12 at 7:55 AM265,514 Shares in Arcus Biosciences, Inc. (NYSE:RCUS) Purchased by Nordea Investment Management ABmarketbeat.com - May 11 at 6:17 AMBTIG Sticks to Its Buy Rating for Arcus Biosciences (RCUS)markets.businessinsider.com - May 10 at 8:04 AMTD Asset Management Inc Buys New Stake in Arcus Biosciences, Inc. (NYSE:RCUS)marketbeat.com - May 10 at 4:51 AMArcus Biosciences, Inc. (NYSE:RCUS) Receives $40.50 Consensus Price Target from Analystsamericanbankingnews.com - May 10 at 2:30 AMArcus Biosciences: Q1 Earnings Insightsmsn.com - May 9 at 10:02 PMArcus Biosciences GAAP EPS of -$1.09 beats by $0.10, revenue of $25M beats by $2.53Mmsn.com - May 9 at 10:02 PMArcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Tops Revenue Estimatesfinance.yahoo.com - May 9 at 10:02 PMArcus Biosciences Reports First Quarter 2023 Financial Results and Provides a Pipeline Updatefinance.yahoo.com - May 9 at 5:01 PMArcus Biosciences earnings: here's what Wall Street expectsmarkets.businessinsider.com - May 9 at 1:59 AMEarnings Preview For Arcus Biosciencesmsn.com - May 8 at 3:57 PMArcus Biosciences (RCUS) Set to Announce Quarterly Earnings on Tuesdayamericanbankingnews.com - May 8 at 8:38 AMArcus Biosciences, Inc. (NYSE:RCUS) Given Consensus Rating of "Moderate Buy" by Brokeragesmarketbeat.com - May 7 at 1:53 AMApellis (APLS) Q1 Earnings Miss, Empaveli & Syfovre Fuel Growthfinance.yahoo.com - May 5 at 12:44 PMArcus Biosciences (RCUS) Scheduled to Post Earnings on Tuesdaymarketbeat.com - May 5 at 9:46 AM31,789 Shares in Arcus Biosciences, Inc. (NYSE:RCUS) Purchased by SG Americas Securities LLCmarketbeat.com - May 2 at 4:57 AMArcus Biosciences (NYSE:RCUS) Stock Price Down 4.9%americanbankingnews.com - April 26 at 6:22 AMArcus Biosciences, Inc. (NYSE:RCUS) Shares Sold by Comerica Bankmarketbeat.com - April 26 at 4:20 AM Get Arcus Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RCUS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MoonLake Immunotherapeutics News Today Protagonist Therapeutics News Today DICE Therapeutics News Today Keros Therapeutics News Today Dynavax Technologies News Today Gemini Therapeutics News Today Agios Pharmaceuticals News Today Zentalis Pharmaceuticals News Today Syndax Pharmaceuticals News Today Taro Pharmaceutical Industries News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NYSE:RCUS) was last updated on 6/8/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcus Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.